Atlas Trials

Crossover Study to Evaluate the Relative Bioavailability and Palatability of a Lenvatinib Suspension Compared to the Capsule Formulation in Adult Healthy Volunteers

Clinical trial NCT02792829 · COMPLETED

Trial details

NCT number
NCT02792829
Sponsor
Eisai Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2014-08-01
Primary completion
2014-08-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.